Latest Headlines
-
BD Receives FDA 510(k) Clearance And CE-IVDR Certification For High-Throughput Enteric Bacterial Panels On BD COR™ System
11/3/2025
BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européenne (CE) marking in the European Union for its Enteric Bacterial Panel* (EBP) and Enteric Bacterial Panel plus* (EBP plus) for the BD COR™ System.
-
SYNERGEN Health Expands Lab Market Reach Through Partnership With Lighthouse Lab Services
10/30/2025
SYNERGEN Health, a leading provider of technology-enabled revenue cycle management (RCM) services and solutions, today announced a strategic collaboration with Lighthouse Lab Services, the nation's premier provider of medical laboratory consulting and management.
-
Bruker Applied Mass Spectrometry Showcases Front-Line Chromatography-Free MS Screening At SOFT 2025
10/29/2025
Bruker Applied Mass Spectrometry will highlight advances in harmonized sample preparation for chromatography-free forensic screening across oral fluid, urine, and blood at the Annual Meeting of the Society of Forensic Toxicologists (SOFT) 2025 in Portland, demonstrating DART-MS technology on the EVOQ DART-TQ⁺ system.
-
Monarch Diagnostics Launches New Clinical Lab In Dallas, Expanding Services To Texas
10/29/2025
Monarch Diagnostics today announced the opening of its newest full-service clinical laboratory in Dallas, Texas.
-
Roche Receives CE Mark For Novel Automated High-Throughput Elecsys Dengue Ag Test To Diagnose Dengue
10/29/2025
Roche announced today that it has received CE mark for its Elecsys Dengue Ag test – a high-throughput, fully automated immunoassay to be used as an aid in the diagnosis of an acute dengue virus infection.
-
Noul Supplies AI Diagnostic Platform miLab™ To Charité, Europe's Leading University Hospital
10/28/2025
Noul Co., Ltd.(CEO David Lim), an AI-driven blood and cancer diagnostics company, announced the supply of its AI-based malaria diagnostic solution miLab™ MAL to Charité – Universitätsmedizin Berlin, Germany's largest and most prestigious university hospital.
-
Cepheid Announces World Health Organization Prequalification Of The Xpert® MTB/XDR Test
10/28/2025
Cepheid today announced that its Xpert® MTB/XDR test has been awarded prequalification status by the World Health Organization (WHO), marking a new milestone in the global fight against tuberculosis (TB).
-
InstantGMP Launches Fully Integrated Laboratory Information Management System (LIMS) Software
10/28/2025
InstantGMP™, the innovators in manufacturing and quality management software for the pharmaceutical, supplement, and biotech industries, today announced the release of its new Laboratory Information Management System (LIMS), a fully integrated quality control (QC) module built directly into the InstantGMP manufacturing platform.
-
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership In Automated Sample Processing
10/28/2025
QIAGEN today announced the 4,000th placement of its QIAcube Connect instrument, a significant milestone in driving automation adoption for sample processing across life science and diagnostic labs.
-
Simple Saliva Test Could Revolutionise Heart Failure Detection
10/27/2025
Detecting acute heart failure in the future could be as simple as testing a saliva sample.